{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:34:50Z","timestamp":1777034090792,"version":"3.51.4"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Rett syndrome (RTT) is a severe neurodevelopmental disorder primarily caused by mutations in the MECP2 gene. Although recent therapeutic advances, such as the approval of Trofinetide, offer partial relief, no comprehensive curative treatment is currently available. Among the emerging strategies, nerve growth factor (NGF) has gained attention due to its neurotrophic and immunomodulatory properties. This review, in addition to discussing the key features of RTT and the role of growth factors, also highlights recent evidence supporting NGF-based strategies for RTT, focusing on two independent studies that tested intranasal administration of NGF-like molecules in Mecp2-mutant mice. Both recombinant human NGF (rhNGF) and a modified, \u201cpainless\u201d variant (hNGFp) improved behavioral (cognitive and motor) symptoms. While rhNGF primarily restored mitochondrial function, hNGFp restored neuroinflammatory responses through microglial regulation. Despite differences in molecular mechanisms and dosages, both molecules demonstrated efficacy without adverse effects, especially when administered intranasally, preventively, and over longer periods. These findings suggest that NGF may act through dual mechanisms, by supporting energy homeostasis and regulating immune responses. The use of intranasal delivery further enhances translational potential by overcoming blood\u2013brain barrier limitations. Together, these studies provide a strong rationale for pursuing NGF-based therapies in RTT and encourage further investigations to optimize dosing, timing, and safety in preclinical and clinical settings.<\/jats:p>","DOI":"10.3389\/fnins.2026.1800227","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:35:46Z","timestamp":1777030546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward an NGF-based therapy for Rett syndrome"],"prefix":"10.3389","volume":"20","author":[{"given":"Giulia","family":"Borgonovo","sequence":"first","affiliation":[{"name":"Bio@SNS Laboratory of Biology, Scuola Normale Superiore","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Tiberi","sequence":"additional","affiliation":[{"name":"Bio@SNS Laboratory of Biology, Scuola Normale Superiore","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Capsoni","sequence":"additional","affiliation":[{"name":"Bio@SNS Laboratory of Biology, Scuola Normale Superiore","place":["Pisa, Italy"]},{"name":"Section of Physiology, Department of Neuroscience and Rehabilitation, University of Ferrara","place":["Ferrara, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Bio@SNS Laboratory of Biology, Scuola Normale Superiore","place":["Pisa, Italy"]},{"name":"European Brain Research Institute (EBRI), Fondazione Rita Levi-Montalcini","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-239","article-title":"Nerve growth factor: from the early discoveries to the potential clinical use","volume":"10","author":"Aloe","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm0696-703","article-title":"The role of endogenous nerve growth factor in human diabetic neuropathy","volume":"2","author":"Anand","year":"1996","journal-title":"Nat. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-9-87","article-title":"Twenty years of surveillance in Rett syndrome: what does this tell us?","volume":"9","author":"Anderson","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/bja\/88.2.234","article-title":"Comparison of predictive models for postoperative nausea and vomiting","volume":"88","author":"Apfel","year":"2002","journal-title":"Br. J. Anaesth."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.284.17.2215","article-title":"Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group","volume":"284","author":"Apfel","year":"2000","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.npep.2004.11.001","article-title":"Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat","volume":"39","author":"Baker","year":"2005","journal-title":"Neuropeptides"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0134-19.2019","article-title":"Mecp2 deletion from cholinergic neurons selectively impairs recognition memory and disrupts cholinergic modulation of the perirhinal cortex","volume":"6","author":"Ballinger","year":"2019","journal-title":"eNeuro"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nlm.2011.05.006","article-title":"Cognitive deficits in Rett syndrome: what we know and what we need to know to treat them","volume":"96","author":"Berger-Sweeney","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"12438","DOI":"10.3390\/ijms241512438","article-title":"Role of neurotrophins in orofacial pain modulation: a review of the latest discoveries","volume":"24","author":"Bonomini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejpn.2020.06.020","article-title":"Rett syndrome as a movement and motor disorder \u2013 a narrative review","volume":"28","author":"Brunetti","year":"2020","journal-title":"Eur. J. Paediatric Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2229400","DOI":"10.1080\/24740527.2023.2229400","article-title":"Caregiver perspectives on pain sensitivity and pain experience in Rett syndrome","volume":"7","author":"Byiers","year":"2023","journal-title":"Can. J. Pain"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(sici)1097-4695(199808)36:2<>3.0.co;2-b","article-title":"Regulation of neurogenesis by growth factors and neurotransmitters","volume":"36","author":"Cameron","year":"1998","journal-title":"J. Neurobiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e17321","DOI":"10.1371\/journal.pone.0017321","article-title":"Taking pain out of NGF: a \u2018painless\u2019 NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity","volume":"6","author":"Capsoni","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/brain\/aww271","article-title":"The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor","volume":"140","author":"Capsoni","year":"2017","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1371\/journal.pone.0037555","article-title":"Intranasal \u2018painless\u2019 human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app X PS1 mice","volume":"7","author":"Capsoni","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbagen.2011.10.015","article-title":"Localization of nerve growth factor (NGF) receptors in the mitochondrial compartment: characterization and putative role","volume":"1820","author":"Carito","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1038\/sj.bjp.0707509","article-title":"Role of the brain-derived neurotrophic factor at glutamatergic synapses: brain-derived neurotrophic factor","volume":"153","author":"Carvalho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1080\/02699052.2017.1376760","article-title":"Intranasal nerve growth factor administration improves cerebral functions in a child with severe traumatic brain injury: a case report","volume":"31","author":"Chiaretti","year":"2017","journal-title":"Brain Inj."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jnc.14685","article-title":"GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA","volume":"149","author":"Chiricozzi","year":"2019","journal-title":"J. Neurochem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jnc.14146","article-title":"Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells","volume":"143","author":"Chiricozzi","year":"2017","journal-title":"J. Neurochem."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/35082088","article-title":"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition","volume":"411","author":"Chuang","year":"2001","journal-title":"Nature"},{"key":"ref001","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbrc.2009.11.146","article-title":"In vitro receptor binding properties of a \u201cpainless\u201d NGF mutein, linked to hereditary sensory autonomic neuropathy type V","volume":"391","author":"Covaceuszach","year":"2010","journal-title":"Biochem Biophys Res Commun."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13062-023-00379-5","article-title":"Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest","volume":"18","author":"Curatola","year":"2023","journal-title":"Biol. Direct"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a Sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0896-6273(92)90213-W","article-title":"The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons","volume":"8","author":"DiStefano","year":"1992","journal-title":"Neuron"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/hmg\/ddh096","article-title":"A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception","volume":"13","author":"Einarsdottir","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00439-011-1029-2","article-title":"Evolutionary diversity and developmental regulation of X-chromosome inactivation","volume":"130","author":"Escamilla-Del-Arenal","year":"2011","journal-title":"Hum. Genet."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13023-022-02519-y","article-title":"Pain in Rett syndrome: a pilot study and a single case study on the assessment of pain and the construction of a suitable measuring scale","volume":"17","author":"Fabio","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.3390\/ijms252111555","article-title":"GM1 oligosaccharide ameliorates Rett syndrome phenotypes in vitro and in vivo via Trk receptor activation","volume":"25","author":"Fazzari","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/REVNEURO.2009.20.2.133","article-title":"Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems","volume":"20","author":"Fiore","year":"2009","journal-title":"Rev. Neurosci."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fpsyt.2017.00126","article-title":"Alterations of growth factors in autism and attention-deficit\/hyperactivity disorder","volume":"8","author":"Galvez-Contreras","year":"2017","journal-title":"Front. Psych."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cytogfr.2016.08.004","article-title":"Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders","volume":"32","author":"Galvez-Contreras","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13062-023-00418-1","article-title":"Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome","volume":"18","author":"Gatto","year":"2023","journal-title":"Biol. Direct"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2741\/s252","article-title":"Intranasal treatment of neurodegenerative diseases and stroke","volume":"4","author":"Gomez","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00246-002-0406-y","article-title":"Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome","volume":"25","author":"Guideri","year":"2004","journal-title":"Pediatr. Cardiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, Ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1016\/0197-4580(94)90204-6","article-title":"Development of effective therapy for Alzheimer\u2019s disease based on neurotrophic factors","volume":"15","author":"Hefti","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.3390\/jcm12155114","article-title":"Trofinetide for Rett syndrome: highlights on the development and related inventions of the first USFDA-approved treatment for rare pediatric unmet medical need","volume":"12","author":"Hudu","year":"2023","journal-title":"J. Clin. Med."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1523\/JNEUROSCI.2778-14.2015","article-title":"Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity","volume":"35","author":"Jin","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the Foundation for Translational Success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40265-023-01883-8","article-title":"Trofinetide: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"21205","DOI":"10.1074\/jbc.M114.563403","article-title":"A Role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress","volume":"289","author":"Kraemer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"31732","DOI":"10.1038\/srep31732","article-title":"Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/088307389601100407","article-title":"Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome","volume":"11","author":"Lappalainen","year":"1996","journal-title":"J. Child Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1194\/jlr.R800009-JLR200","article-title":"Thematic review series: sphingolipids. Nuclear sphingolipids: metabolism and signaling","volume":"49","author":"Ledeen","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0887-8994(91)90082-v","article-title":"Membrane cerebral lipids in Rett syndrome","volume":"7","author":"Lekman","year":"1991","journal-title":"Pediatr. Neurol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1090-3798(99)90099-5","article-title":"Cerebrospinal fluid gangliosides in patients with Rett syndrome and infantile neuronal ceroid lipofuscinosis","volume":"3","author":"Lekman","year":"1999","journal-title":"Eur. J. Paediatric Neurol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1749-6632.1952.tb26548.x","article-title":"Effects of mouse tumor transplantation on the nervous system","volume":"55","author":"Levi-Montalcini","year":"1952","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref59","first-page":"217","article-title":"The nerve growth factor: its mode of action on sensory and sympathetic nerve cells","volume":"60","author":"Levi-Montalcini","year":"1966","journal-title":"Harvey Lect."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0166-2236(93)90092-z","article-title":"Nerve growth factor and nociception","volume":"16","author":"Lewin","year":"1993","journal-title":"Trends Neurosci."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1523\/JNEUROSCI.13-05-02136.1993","article-title":"Nerve growth factor-induced hyperalgesia in the neonatal and adult rat","volume":"13","author":"Lewin","year":"1993","journal-title":"J. Neurosci."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnen\/59.10.889","article-title":"Reduced nerve growth factor in Rett syndrome postmortem brain tissue","volume":"59","author":"Lipani","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1523\/JNEUROSCI.17-24-09573.1997","article-title":"Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes","volume":"17","author":"Lockhart","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e0136425","DOI":"10.1371\/journal.pone.0136425","article-title":"Functional characterization of human proNGF and NGF mutants: identification of NGF P61SR100E as a \u2018painless\u2019 lead investigational candidate for therapeutic applications","volume":"10","author":"Malerba","year":"2015","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/17425247.2011.588204","article-title":"Intranasal delivery of therapeutic proteins for neurological diseases","volume":"8","author":"Malerba","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"754502","DOI":"10.3389\/fphar.2021.754502","article-title":"Intranasal delivery of nerve growth factor in neurodegenerative diseases and Neurotrauma","volume":"12","author":"Manni","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","article-title":"Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death","volume":"26","author":"Massa","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1212\/wnl.54.5.1080","article-title":"A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection","volume":"54","author":"McArthur","year":"2000","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0301-0082(98)00059-8","article-title":"Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases","volume":"57","author":"Mufson","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-020-01655-7","article-title":"Fingolimod in children with Rett syndrome: the FINGORETT study","volume":"16","author":"Naegelin","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1073858403260995","article-title":"Rett syndrome: a prototypical neurodevelopmental disorder","volume":"10","author":"Neul","year":"2004","journal-title":"Neuroscientist"},{"key":"ref73","first-page":"S21","article-title":"Motor symptoms of the Rett syndrome: abnormal muscle tone, posture, locomotion and stereotyped movement","volume":"14","author":"Nomura","year":"1992","journal-title":"Brain Dev."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","article-title":"Neurodevelopmental effects of insulin-like growth factor signaling","volume":"33","author":"O\u2019Kusky","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/17518423.2015.1087437","article-title":"Detecting autonomic response to pain in Rett syndrome","volume":"20","author":"O\u2019Leary","year":"2017","journal-title":"Dev. Neurorehabil."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after Ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0006-8993(97)01525-4","article-title":"Permeability of the blood-brain barrier to neurotrophins","volume":"788","author":"Pan","year":"1998","journal-title":"Brain Res."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002093-199040100-00001","article-title":"Nerve growth factor and the basal forebrain cholinergic system: a link in the etiopathology of neurodegenerative dementias?","volume":"4","author":"Perry","year":"1990","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ana.410360221","article-title":"The effect of systemically administered recombinant human nerve growth factor in healthy human subjects","volume":"36","author":"Petty","year":"1994","journal-title":"Ann. Neurol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0014-5793(98)01344-1","article-title":"Influence of endogenous GM1 ganglioside on TrkB activity, in cultured neurons","volume":"439","author":"Pitto","year":"1998","journal-title":"FEBS Lett."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0169-328x(95)00250-v","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Mol. Brain Res."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/brain\/awae291","article-title":"Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice","volume":"148","author":"Pozzer","year":"2025","journal-title":"Brain"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"776809","DOI":"10.3389\/fnins.2021.776809","article-title":"The epigenome in neurodevelopmental disorders","volume":"15","author":"Reichard","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"146644","DOI":"10.1016\/j.brainres.2019.146644","article-title":"Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development","volume":"1729","author":"Ribeiro","year":"2020","journal-title":"Brain Res."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/glia.23312","article-title":"NGF steers microglia toward a neuroprotective phenotype","volume":"66","author":"Rizzi","year":"2018","journal-title":"Glia"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1073\/pnas.0500195102","article-title":"Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1408587","DOI":"10.3389\/fopht.2024.1408587","article-title":"The use of Rh-NGF in the management of neurotrophic keratopathy","volume":"4","author":"Roszkowska","year":"2024","journal-title":"Front. Ophthalmol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/bjophthalmol-2018-312470","article-title":"Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study","volume":"104","author":"Sacchetti","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e15224","DOI":"10.7554\/elife.15224","article-title":"Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression","volume":"5","author":"Schafer","year":"2016","journal-title":"eLife"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41591-024-02977-w","article-title":"p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial","volume":"30","author":"Shanks","year":"2024","journal-title":"Nat. Med."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.1523\/JNEUROSCI.0481-11.2011","article-title":"Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain","volume":"31","author":"Shinoda","year":"2011","journal-title":"J. Neurosci."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2017.00058","article-title":"Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies","volume":"11","author":"Shulyakova","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0304-3940(94)90448-0","article-title":"Increased levels of NGF protein and mRNA and reactive gliosis following Kainic acid injection into the rat striatum","volume":"168","author":"Strauss","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"190574","DOI":"10.1098\/rsos.190574","article-title":"Contrasting characteristic Behaviours among common laboratory mouse strains","volume":"6","author":"Sultana","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/AJP.0b013e318274b6bd","article-title":"Parent-reported pain in Rett syndrome","volume":"29","author":"Symons","year":"2013","journal-title":"Clin. J. Pain"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/brain\/awad282","article-title":"Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome","volume":"147","author":"Tiberi","year":"2024","journal-title":"Brain"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/cells11111835","article-title":"A microglial function for the nerve growth factor: predictions of the unpredictable","volume":"11","author":"Tiberi","year":"2022","journal-title":"Cells"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/biomedicines12112624","article-title":"P75NTR modulation reduces oxidative stress and the expression of pro-inflammatory mediators in a cell model of Rett syndrome","volume":"12","author":"Varone","year":"2024","journal-title":"Biomedicine"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature14444","article-title":"Wild-type microglia do not reverse pathology in mouse models of Rett syndrome","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1002\/jnr.21808","article-title":"The p75 receptor is associated with inflammatory thermal hypersensitivity","volume":"86","author":"Watanabe","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2007-973476","article-title":"Altered cholinergic function in the basal forebrain of girls with Rett syndrome","volume":"30","author":"Wenk","year":"1999","journal-title":"Neuropediatrics"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0165-3806(93)90084-N","article-title":"Neurochemical alterations in Rett syndrome","volume":"74","author":"Wenk","year":"1993","journal-title":"Brain Res. Dev. Brain Res."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00439-011-0994-9","article-title":"X-chromosome inactivation: molecular mechanisms from the human perspective","volume":"130","author":"Yang","year":"2011","journal-title":"Hum. Genet."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13229-017-0134-z","article-title":"Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia\/macrophage activation and cellular stress","volume":"8","author":"Zhao","year":"2017","journal-title":"Mol. Autism."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbr.2017.01.023","article-title":"Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2 stop mice","volume":"322","author":"Zhou","year":"2017","journal-title":"Behav. Brain Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1800227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:35:47Z","timestamp":1777030547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1800227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":110,"alternative-id":["10.3389\/fnins.2026.1800227"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1800227","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1800227"}}